BioHarvest Sciences Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
BioHarvest Sciences Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Revenue & Gross Profit
Revenue25.1912.675.502.100.40
Cost of Revenue11.257.044.281.430.26
Gross Profit13.945.631.220.670.14
Operating Expenses
Research & Development4.803.372.314.131.26
Selling, General & Administrative15.7412.089.524.764.44
Operating Expenses20.9315.6011.839.165.71
Operating Income-6.99-9.97-10.61-8.49-5.57
Other Income/Expense
Interest Income0.000.000.000.000.00
Interest Expense1.931.96-0.510.81-0.50
Other Income/Expense-5.92-0.50-0.35-0.480.15
Income
Income Before Tax-12.91-12.56-11.24-9.83-6.58
Income Tax Expense0.010.000.000.000.00
Net Income-12.91-12.56-11.24-9.83-6.58
Net Income - Continuous Operations-12.91-12.56-11.24-9.830.00
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA-9.72-9.76-10.33-8.63-5.52
EBIT-8.17-10.60-10.61-9.02-5.57
Depreciation & Amortization1.250.150.290.270.05
Earnings Per Share
Basic EPS-1.00-1.00-1.00-1.00-1.00
Diluted EPS-1.00-1.00-1.00-1.00-1.00
Basic Shares Outstanding16.1913.5313.0512.459.71
Diluted Shares Outstanding16.1913.5313.0512.459.71